Iowa HSB209 mandates the Department of Health and Human Services to review anti-obesity medications for Medicaid.
Iowa HSB209 requires the Department of Health and Human Services to review anti-obesity medications for effectiveness, impact on comorbidities, potential cost savings, and recommended eligibility requirements. The department must submit a report to the general assembly by December 1, 2025, detailing its findings and proposed eligibility requirements. This review is intended to inform the medical assistance program, also known as Medicaid.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.